Fidelity Disruptive Medicine ETF
FMED
8 hedge funds and large institutions have $32.3M invested in Fidelity Disruptive Medicine ETF in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 0 closing their positions.
14% more funds holding
Funds holding: 7 → 8 (+1)
2.13% more ownership
Funds ownership: 59.71% → 61.84% (+2.1%)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
3% less capital invested
Capital invested by funds: $33.3M → $32.3M (-$947K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
|
+$1.13M |
| 2 |
Jane Street
New York
|
+$117K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$83.4K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$11.1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Fidelity Investments
Boston,
Massachusetts
| $16.3M | -$83.4K | -3,236 | -0.5% |
|
|
2
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
| $14.4M | +$1.13M | +43,788 | +8% |
|
|
3
Jane Street
New York
| $1.62M | +$117K | +4,541 | +7% |
|
|
PSFG
4
Park Square Financial Group
Roswell,
Georgia
| $14.5K | +$15.2K | +589 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| $5.18K | -$11.1K | -431 | -67% |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $4K | – | – | – |
|
|
CPBTD
7
Central Pacific Bank - Trust Division
Honolulu,
Hawaii
| $2.39K | – | – | – |
|
|
GEA
8
Glen Eagle Advisors
Kingston,
New Jersey
| $2.22K | – | – | – |
|
FMED Hedge Fund Activity: Q4 2024 in Review
8 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Fidelity Disruptive Medicine ETF (FMED) for Q4 2024, worth a combined $32.3M — down 2.8% from $33.3M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new FMED positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Wealth Enhancement Advisory Services, adding an estimated $1.13M. The largest seller was Fidelity Investments, cutting an estimated $83.4K.
- 8 institutional investors held Fidelity Disruptive Medicine ETF (FMED) as of Q4 2024, up from 7 in Q3 2024.
- Funds reported $32.3M of Fidelity Disruptive Medicine ETF stock for Q4 2024, down 2.8% quarter-over-quarter.
- 1 fund opened new Fidelity Disruptive Medicine ETF positions in Q4 2024 and 0 closed out, a net change of +1 holder.
- The largest Fidelity Disruptive Medicine ETF buyer in Q4 2024 was Wealth Enhancement Advisory Services, an estimated $1.13M added.
- The largest Fidelity Disruptive Medicine ETF seller in Q4 2024 was Fidelity Investments, an estimated $83.4K sold.
Based on aggregated 13F filings for Q4 2024.